Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma

Bullement, A; Nathan, P; Willis, A; Amin, A; Lilley, C; Stapelkamp, C; Hatswell, A; Pescott, C; Bharmal, M

Bharmal, M (reprint author), Merck KGaA, Darmstadt, Germany.

PHARMACOECONOMICS-OPEN, 2019; 3 (3): 377

Abstract

Background Metastatic Merkel cell carcinoma (mMCC) is a rare and aggressive skin cancer. Until recently, there were no licensed treatment options for ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索